Quick answer: KPV is the three-residue peptide Lys-Pro-Val, which matches the C-terminal end of alpha-melanocyte-stimulating hormone (alpha-MSH). Researchers study it as a small, stable fragment that keeps some of the parent hormone's signaling-related behavior in cell and animal models. It is a laboratory research compound only. This guide explains the name, the structure, what the literature actually examines, how it differs from similar peptides, and what to check on a certificate of analysis.
What does “KPV” stand for?
The name is simply the one-letter amino acid code for the sequence: K for lysine, P for proline, V for valine. Written in full it is Lys-Pro-Val. Because the molecule is only three residues long, labs usually describe it as a tripeptide, and its molecular weight sits near 342 g/mol, far smaller than most catalog peptides.
In supplier listings you will see the same compound called “KPV peptide,” “alpha-MSH (11-13),” or “the C-terminal tripeptide of alpha-MSH.” Those are all the same sequence. It should not be confused with GHK-KPV, a different research compound in which a copper-binding tripeptide is joined to KPV. If a product page does not make clear which one you are looking at, ask before ordering.
The short name has become a search term of its own, which is why so many people land on pages that assume prior knowledge. The aim of this explainer is to cover that missing background in plain language, using only preclinical research as the frame.
Where KPV comes from: the alpha-MSH connection
Alpha-MSH is a 13-residue hormone cleaved from the larger precursor proopiomelanocortin (POMC). It is best known in the literature for acting on melanocortin receptors, a family of G protein-coupled receptors involved in pigmentation, energy balance and immune signaling. The final three residues of alpha-MSH, at positions 11 to 13, are Lys-Pro-Val.
Early structure-activity work on alpha-MSH asked which part of the molecule carries which behavior. Several groups reported that the C-terminal fragment retained some of the immune-related activity seen with the full hormone in cell assays, even though it lacks the central core sequence that is generally associated with melanocortin receptor binding. That observation made KPV an attractive minimal probe: a very small molecule that can be made cleanly and handled easily in vitro.
For the full story of how the fragment was characterized, see our write-up on the discovery and history of KPV, and for the receptor context see KPV vs. alpha-MSH: a melanocortin comparison.
What researchers actually study it for
Published work on KPV is preclinical. The main themes are summarized below, and none of them describe a use in people.
Inflammatory signaling in cell models. Studies in cultured immune and epithelial cells have examined whether KPV changes the activity of pro-inflammatory signaling pathways, including NF-kB related readouts and the release of cytokines such as TNF-alpha and interleukin-6 after an inflammatory stimulus.
Transport into cells. One often-cited line of work reported that KPV can be taken up by the peptide transporter PepT1 in intestinal epithelial cell lines. This matters to researchers because it offers a possible explanation for how such a short peptide reaches an intracellular site, and it is why intestinal cell and gut-inflammation animal models appear so often in the KPV literature.
Animal models of mucosal inflammation. Several rodent studies used chemically induced colitis models to compare KPV with vehicle controls. These are model-system observations and they are not evidence about how the molecule behaves outside the laboratory.
Skin and barrier models. A smaller body of work looks at keratinocyte and fibroblast cultures, again as a signaling question.
We cover the mechanistic literature in more depth in the KPV mechanism of action article and the animal and cell data in KPV preclinical research.
KPV compared with related research peptides
Because the name is short and the sequence is small, KPV is often grouped with other peptides that are studied for signaling or tissue questions. The table below shows how they differ on basic descriptors. It is a reading aid for the literature, not a ranking.
| Compound | Approx. length | Origin | Typical research context |
|---|---|---|---|
| KPV | 3 residues (Lys-Pro-Val) | C-terminal fragment of alpha-MSH | Cell signaling, epithelial uptake, mucosal inflammation models |
| Alpha-MSH | 13 residues | POMC cleavage product | Melanocortin receptor pharmacology, pigmentation, immune signaling |
| GHK-KPV | 5 residues (Gly-His-Lys + Lys-Pro-Val) | Hybrid of GHK and KPV | Combined copper-binding and KPV signaling questions |
| Selank | 7 residues | Tuftsin analog | Neuropeptide and immune-signaling models |
Storage and handling basics for the lyophilized form
KPV is normally supplied as a freeze-dried powder, which is the form that is most stable for shipping and storage. General laboratory practice for lyophilized peptides applies: keep the sealed vial cold and dry, protect it from light, and avoid repeated warming and cooling of the container. Once a vial is opened and the material is dissolved, stability falls, so labs typically plan work to use solutions within a short window and keep records of when each vial was opened.
Our guide to KPV storage and reconstitution handling covers the practical points, and what lyophilization is explains why the powder form is preferred.
What to check on a KPV certificate of analysis
A tripeptide is simple to synthesize, so purity differences between suppliers tend to come from the purification step and from how carefully the final material is documented rather than from synthesis difficulty. When you compare listings, look for the following on any certificate you are shown.
An HPLC purity figure with the chromatogram. A bare percentage with no trace is hard to evaluate. A very small molecule like KPV should show one dominant peak. See understanding HPLC purity for how to read it.
An identity check. Many buyers look for mass spectrometry that confirms the expected mass. Consider that a generic buying criterion: ask whichever supplier you use what identity method their document reports, and read the document itself to see.
A lot or batch reference that matches the vial in your hands, plus a test date and the issuing laboratory's name.
Net peptide content or fill amount. Lyophilized peptides contain counter-ions and water, so the label amount and the active peptide mass are not always identical.
Our guide to reading a COA walks through each section, and KPV purity testing applies it to this compound. If you are comparing sources, where to buy KPV: a sourcing checklist lists the questions to ask. Product details for our listing are on the KPV product page.
Common misunderstandings
“KPV is the same as alpha-MSH.” It is not. It is a three-residue fragment of a thirteen-residue hormone, and the two have different sizes, properties and receptor behavior in the literature.
“KPV and GHK-KPV are interchangeable.” They are different molecules with different molecular weights. Compare the GHK-KPV overview if you need the distinction.
“Small peptide means simple documentation.” Short sequences still need a proper purity trace and identity confirmation.
“A study in mice tells us what happens in people.” It does not, and no claim of that kind is made here.
Frequently asked questions
What does KPV stand for?
The letters are the one-letter codes for lysine, proline and valine. KPV is the tripeptide Lys-Pro-Val.
Is KPV the same thing as alpha-MSH?
No. KPV matches the last three residues of alpha-MSH, which is thirteen residues long. It is a fragment, not the full hormone.
Is KPV the same as GHK-KPV?
No. GHK-KPV is a joined compound that adds a GHK tripeptide to KPV, so it is larger and has a different molecular weight.
How big is the KPV molecule?
About 342 g/mol, which makes it one of the smallest peptides in a typical research catalog.
Is KPV approved for any use?
No. It is not approved as a drug anywhere that we are aware of, and it is sold for laboratory research only.
What kinds of studies mention KPV?
Cell culture work on inflammatory signaling, intestinal epithelial transport studies involving PepT1, and rodent colitis models. All of it is preclinical.
Why does a three-residue peptide need a certificate of analysis?
Because purity, identity and fill amount still vary between sources. A chromatogram and a lot reference let you verify the material you actually hold.
How is lyophilized KPV usually stored?
Sealed, cold, dry and away from light, with repeated temperature cycling avoided. Our storage article covers the details.
Can I tell from the name which KPV product I am buying?
Not always. Check that the listing says KPV alone rather than a blend or a hybrid such as GHK-KPV, and confirm the stated vial amount.
Where can I read more about KPV?
Start with the research overview and mechanism articles linked above, then the preclinical research page for the model-system data.
References
- Dalmasso G, et al. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology. 2008;134(1):166-178.
- Kannengiesser K, et al. Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease. Inflammatory Bowel Diseases. 2008;14(3):324-331.
- Catania A, Gatti S, Colombo G, Lipton JM. Targeting melanocortin receptors as a novel strategy to control inflammation. Pharmacological Reviews. 2004;56(1):1-29.
- Brzoska T, et al. Alpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases. Endocrine Reviews. 2008;29(5):581-602.
All V8 Peptides products are sold for laboratory research use only. They are not drugs, foods, or cosmetics and are not intended for human or animal consumption.